secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0000950170-25-070346
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro reports record Q1 revenue $8.5M, consumables up 104% YoY
-------------------------------------------------------------------------

- Q1 revenue $8.5M (record), up 11% YoY; consumable product revenue grew 104% to $5.5M.
- Neurosurgery navigation therapy revenue up 70% to $3.3M; biologics & drug delivery revenue up 9% to $4.7M.
- Gross margin 60% (vs 59%); opEx up 29% to $11.3M on higher R&D and headcount.
- Cash $12.4M at Mar 31 (down from $20.1M Dec 2024); credit facility secured with Oberland Capital.
- FY 2025 revenue guidance reaffirmed at $36M-$41M; FDA clearance for ClearPoint 3.0 software.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000095017025070346/0000950170-25-070346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000095017025070346/clpt-20250513.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-070346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer